Glide(US) | $15,000,000 | (May 9, 2025)
Kouper | $10,000,000 | (May 9, 2025)
Doubleword (prev. TitanML) | $12,000,000 | (May 9, 2025)
Certified by Founder
Lodge
ADARx Pharmaceuticals Inc.
start up
United States
- San Diego, CA
- 10/08/2023
- Series C
- $200,000,000
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. We are well-financed by a syndicate of renowned VC firms.
ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.
- Industry Biotechnology Research
- Website https://www.adarx.com/
- LinkedIn https://www.linkedin.com/company/adarx-pharmaceuticals-inc/
VESTIGAS | $9,003,240 | (May 9, 2025)
HAYA Therapeutics | $65,000,000 | (May 9, 2025)
Una Software | $4,400,000 | (May 9, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)
Jozu | $4,000,000 | (May 9, 2025)
PATH EX, Inc. | $5,000,000 | (May 9, 2025)
Blank Beauty | Undisclosed Amount | (May 9, 2025)
Pulse Charter Connect | $2,000,000 | (May 9, 2025)
CodeAnt AI (YC W24) | $2,000,000 | (May 8, 2025)